Drug intelligence / Profile preview

pantetheine

Development stage
Preclinical
Lead developer
United States Department of Veterans Affairs
Modality
Small Molecules
Administration
Oral
01

Overview

Pantetheine is a naturally occurring cysteamine amide analog of pantothenic acid (vitamin B5) and an intermediate in the biosynthesis of coenzyme A (CoA). It is the monomeric precursor to pantethine, a widely used dietary supplement. Pantetheine can be phosphorylated by pantothenate kinases (PANK) to form 4'-phosphopantetheine, bypassing upstream rate-limiting steps of the canonical CoA biosynthetic pathway. In preclinical models of progressive multiple sclerosis (MS), pantetheine has been shown to rescue astrocytes from ferroptosis induced by liver kinase B1 (LKB1) deficiency, restoring metabolic resilience and iron homeostasis. It is being investigated by researchers at the University of Illinois at Chicago and the Department of Veterans Affairs as a potential therapeutic strategy for neurodegenerative and demyelinating diseases.

Other names
(R)-pantetheineD-pantetheineLactobacillus bulgaricus growth factorpantetheine monomer
02

Targets

CoA (Coenzyme A)DPCK (Dephospho-CoA kinase)PPAT (Phosphopantetheine adenylyltransferase)

Beyond the preview

Go deeper on pantetheine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pantetheine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call